Virginia Bio adds MedImmune executive to board
Published
Virginia Bio has named Dr. Reg Seeto to its board of directors.
Seeto is vice president, head of partnering and strategy at MedImmune, the biologics research arm of AstraZeneca.
Seeto joined MedImmune in 2008 and has held many leadership roles with the company. In 2013, he assumed his current role and now leads the company’s Partnering and Strategy Group.
Before joining MedImmune, Seeto was vice president of global marketing for Schering Plough/Organon Biosciences and executive director of U.S. Marketing for Boehringer Ingelheim Pharmaceuticals.
Virginia Bio is nonprofit trade association for life sciences and is an advocate for the biopharmaceutical and device industries among federal, state and local policy makers.
